{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T20:28:06Z","timestamp":1779222486252,"version":"3.51.4"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019163","name":"Instituto Nacional de Ci\u00eancia e Tecnologia em Tuberculose","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019163","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["404440\/2016-9"],"award-info":[{"award-number":["404440\/2016-9"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005855","name":"Universidade Nova de Lisboa","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007374","name":"Universidade Federal de Minas Gerais","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017654","name":"Banco Nacional de Desenvolvimento Econ\u00f4mico e Social","doi-asserted-by":"publisher","award":["0914.1"],"award-info":[{"award-number":["0914.1"]}],"id":[{"id":"10.13039\/501100017654","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.tube.2021.102089","type":"journal-article","created":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T12:12:07Z","timestamp":1620907927000},"page":"102089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Effects of tafenoquine against active, dormant and resistant Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"128","author":[{"given":"Maria Gabriella S.","family":"Sidr\u00f4nio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Paula O.T.","family":"Castelo Branco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno L.","family":"Abbadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda","family":"Macchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiele D.","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6513-0381","authenticated-orcid":false,"given":"Graziela de A.","family":"Lock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa Dalla","family":"Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dem\u00e9trius M.","family":"de Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Cibulski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiano V.","family":"Bizarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Augusto","family":"Basso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valn\u00eas S.","family":"Rodrigues-Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2021.102089_bib1","series-title":"Global Health Estimates 2016: deaths by cause, age, sex, by country and by region, 2000-2016","author":"World Health Organization","year":"2018"},{"key":"10.1016\/j.tube.2021.102089_bib2","doi-asserted-by":"crossref","first-page":"112175","DOI":"10.1016\/j.ejmech.2020.112175","article-title":"Repurposed drug candidates for antituberculosis therapy","volume":"192","author":"An","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.tube.2021.102089_bib3","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tube.2009.07.002","article-title":"New anti-tuberculosis agents amongst known drugs","volume":"89","author":"Lougheed","year":"2009","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2021.102089_bib4","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1128\/AAC.34.11.2217","article-title":"Inhibition of tubercle bacilli in cultured human macrophages by chloroquine used alone and in combination with streptomycin, isoniazid, pyrazinamide, and two metabolites of vitamin D3","volume":"34","author":"Crowle","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102089_bib5","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1128\/AAC.43.8.1870","article-title":"Mefloquine is active in vitro and in vivo against Mycobacterium avium complex","volume":"43","author":"Bermudez","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102089_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijantimicag.2016.04.029","article-title":"Mefloquine and its oxazolidine derivative compound are active against drug-resistant Mycobacterium tuberculosis strains and in a murine model of tuberculosis infection","volume":"48","author":"Rodrigues-Junior","year":"2016","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tube.2021.102089_bib7","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1183\/13993003.00321-2015","article-title":"Mefloquine as a potential drug against drug-resistant tuberculosis","volume":"46","author":"Krieger","year":"2015","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2021.102089_bib8","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1128\/AAC.00790-10","article-title":"Tafenoquine, an antiplasmodial 8-aminoquinoline, targets Leishmania respiratory complex III and induces apoptosis","volume":"54","author":"Carvalho","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102089_bib9","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1128\/AAC.00879-15","article-title":"The oral antimalarial drug tafenoquine shows activity against Trypanosoma brucei","volume":"59","author":"Carvalho","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2021.102089_bib10","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/jac\/dkm207","article-title":"Resazurin reduction assays for screening of anti-tubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis","volume":"60","author":"Taneja","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.tube.2021.102089_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0202568","article-title":"Pre-clinical evaluation of quinoxaline-derived chalcones in tuberculosis","volume":"13","author":"Murad\u00e1s","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.tube.2021.102089_bib12","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1365-2958.2002.02779.x","article-title":"Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling","volume":"43","author":"Betts","year":"2002","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.tube.2021.102089_bib13","article-title":"In vitro activity of rifampicin and verapamil combination in multidrug-resistant Mycobacterium tuberculosis","volume":"10","author":"Demitto","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.tube.2021.102089_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2323\/jgam.53.333","article-title":"Evaluation of Mycobacterium smegmatis as a possible surrogate screen for selecting molecules active against multi-drug resistant Mycobacterium tuberculosis","volume":"53","author":"Chaturvedi","year":"2007","journal-title":"J Gen Appl Microbiol"},{"key":"10.1016\/j.tube.2021.102089_bib15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1186\/1471-2164-15-991","article-title":"Unraveling Mycobacterium tuberculosis genomic diversity and evolution in Lisbon, Portugal, a highly drug resistant setting","volume":"15","author":"Perdig\u00e3o","year":"2014","journal-title":"BMC Genom"},{"key":"10.1016\/j.tube.2021.102089_bib16","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1086\/379718","article-title":"Plasma concentrations of tafenoquine, a new long-acting antimalarial agent, in Thai soldiers receiving monthly prophylaxis","volume":"37","author":"Edstein","year":"2003","journal-title":"Clin Infect Dis"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979221000391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979221000391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:46:06Z","timestamp":1761468366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979221000391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":16,"alternative-id":["S1472979221000391"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2021.102089","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of tafenoquine against active, dormant and resistant Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2021.102089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102089"}}